Christopher L King Selected Research

Antigens

1/2023	IgG4 antibodies to the recombinant filarial antigen Wb-Bhp-1 decrease dramatically following treatment of lymphatic filariasis.
1/2022	Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections.
1/2022	Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
4/2021	Triple-Drug Treatment Is Effective for Lymphatic Filariasis Microfilaria Clearance in Samoa.
1/2021	Molecular Diagnosis of SARS-CoV-2: Assessing and Interpreting Nucleic Acid and Antigen Tests.
1/2018	Changes in Cytokine, Filarial Antigen, and DNA Levels Associated With Adverse Events Following Treatment of Lymphatic Filariasis.
12/2017	Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in children.
1/2017	P. falciparum infection and maternofetal antibody transfer in malaria-endemic settings of varying transmission.
1/2017	Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development.
1/2016	Adhesion of Plasmodium falciparum infected erythrocytes in ex vivo perfused placental tissue: a novel model of placental malaria.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher L King Research Topics

Disease

50	Infections 03/2024 - 08/2002
45	Malaria 02/2024 - 01/2002
29	Filarial Elephantiasis (Lymphatic Filariasis) 01/2023 - 11/2005
10	COVID-19 03/2024 - 01/2021
8	Onchocerciasis 01/2023 - 01/2017
8	Vivax Malaria 01/2019 - 03/2010
5	Falciparum Malaria (Plasmodium falciparum Malaria) 03/2024 - 10/2010
5	Filariasis 01/2022 - 09/2003
4	HIV Infections (HIV Infection) 01/2019 - 09/2010
4	Schistosomiasis (Bilharziasis) 11/2018 - 11/2005
4	Parasitemia 12/2017 - 07/2006
3	Neglected Diseases 08/2020 - 01/2019
3	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2019 - 02/2016
3	Parasitic Diseases (Parasitic Disease) 04/2017 - 02/2014
3	Reinfection 01/2012 - 08/2003
2	Hepatitis B 10/2023 - 01/2015
2	Vaccine-Preventable Diseases 10/2023 - 05/2009
2	Breakthrough Infections 04/2023 - 01/2023
2	Hematuria 01/2023 - 02/2016
2	Coinfection 01/2016 - 11/2005
2	Anemia 02/2014 - 07/2009
1	Lymphedema (Milroy Disease) 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Rheumatoid Arthritis 01/2023
1	Bacterial Infections (Bacterial Infection) 10/2022
1	Loiasis 01/2022
1	Scabies (Sarcoptic Mange) 11/2021
1	Body Weight (Weight, Body) 01/2021
1	Trachoma 08/2020
1	Yaws 08/2020
1	Premature Birth (Birth, Premature) 01/2019
1	Iron Deficiencies 01/2018
1	Malnutrition (Nutritional Deficiencies) 01/2018
1	Growth Disorders 04/2017

Drug/Important Bio-Agent (IBA)

32	AntigensIBA 01/2023 - 08/2002
24	VaccinesIBA 04/2023 - 07/2004
18	Albendazole (Albenza)FDA Link 01/2023 - 01/2008
18	Immunoglobulin G (IgG)IBA 01/2023 - 07/2004
18	Ivermectin (Mectizan)FDA Link 01/2023 - 09/2014
16	AntibodiesIBA 10/2023 - 08/2003
15	Diethylcarbamazine (Hetrazan)FDA Link 01/2023 - 01/2008
11	Carrier Proteins (Binding Protein)IBA 03/2023 - 08/2002
8	Neutralizing AntibodiesIBA 03/2024 - 02/2016
8	Proteins (Proteins, Gene)FDA Link 02/2024 - 06/2005
7	LigandsIBA 03/2023 - 01/2002
7	Merozoite Surface Protein 1 (MSA1)IBA 01/2016 - 01/2002
6	CytokinesIBA 11/2018 - 12/2004
4	Blood Group Antigens (Blood Groups)IBA 12/2023 - 01/2004
4	Messenger RNA (mRNA)IBA 02/2023 - 11/2021
3	BNT162 VaccineIBA 02/2023 - 11/2021
3	mRNA VaccinesIBA 02/2023 - 01/2023
3	EpitopesIBA 01/2019 - 05/2003
3	Biomarkers (Surrogate Marker)IBA 01/2016 - 07/2013
3	Malaria VaccinesIBA 07/2013 - 07/2004
2	Combined VaccinesIBA 03/2024 - 04/2023
2	COVID-19 VaccinesIBA 03/2024 - 01/2023
2	Hemoglobins (Hemoglobin)IBA 03/2024 - 02/2014
2	EnzymesIBA 02/2024 - 07/2004
2	SARS-CoV-2 spike proteinIBA 02/2023 - 01/2021
2	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023 - 01/2023
2	moxidectinIBA 01/2023 - 01/2023
2	Interleukin-2 (IL2)IBA 01/2023 - 07/2009
2	Azithromycin (Zithromax)FDA LinkGeneric 10/2022 - 08/2020
2	Praziquantel (Biltricide)FDA Link 01/2022 - 01/2016
2	Subunit VaccinesIBA 01/2019 - 01/2019
2	Interleukin-10 (Interleukin 10)IBA 11/2018 - 07/2009
2	IronIBA 01/2018 - 02/2014
2	Surface Antigens (Surface Antigen)IBA 12/2017 - 01/2016
2	ChemokinesIBA 11/2016 - 01/2013
2	Antimalarials (Antimalarial Agents)IBA 01/2016 - 09/2005
2	pyrimethamine drug combination fanasil (Fansidar)FDA Link 07/2014 - 02/2014
2	Interleukin-5 (Interleukin 5)IBA 07/2009 - 04/2006
2	Interleukin-13IBA 07/2009 - 04/2006
1	Primaquine FDA Link 03/2024
1	Cytochromes b (Cytochrome b)IBA 02/2024
1	ImmunosorbentsIBA 02/2024
1	AnthelminticsIBA 01/2023
1	LactonesIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2022
1	Permethrin (Ambush)FDA LinkGeneric 11/2021
1	P-30 composite resin (P 30)IBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	CreatinineIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2019
1	InsecticidesIBA 10/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Arginine (L-Arginine)FDA Link 10/2017
1	Histidine (L-Histidine)FDA Link 10/2017
1	insulin receptor-related receptor (IRR)IBA 10/2017
1	Conjugate VaccinesIBA 04/2017

Therapy/Procedure

19	Mass Drug Administration 01/2023 - 01/2008
5	Home Nursing (Nursing, Home) 03/2024 - 01/2022
4	Aftercare (After-Treatment) 01/2023 - 02/2016
4	Drug Therapy (Chemotherapy) 01/2020 - 02/2016
2	Therapeutics 02/2024 - 01/2013
2	Prenatal Care (Care, Prenatal) 07/2014 - 02/2014
1	Long-Term Care 11/2021